SHARE CAPITAL (Details Narrative) |
3 Months Ended | 9 Months Ended | 12 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Nov. 19, 2024
USD ($)
shares
|
Aug. 21, 2024
USD ($)
shares
|
Aug. 07, 2024
$ / shares
|
Apr. 29, 2024
USD ($)
shares
|
Feb. 26, 2024
USD ($)
shares
|
Mar. 31, 2025
CAD ($)
$ / shares
shares
|
Mar. 31, 2024
CAD ($)
shares
|
Dec. 31, 2024
CAD ($)
|
Dec. 31, 2024
shares
|
Mar. 27, 2024
$ / shares
|
Mar. 26, 2024
$ / shares
|
|
| IfrsStatementLineItems [Line Items] | |||||||||||
| Proceeds from issue of ordinary shares | $ 5,272,234 | $ 2,720,050 | $ 4,882,168 | $ 4,877,475 | |||||||
| Issuance cost | 755,387 | 343,676 | 779,615 | $ 306 | $ 266,651 | $ 856,766 | |||||
| Net proceeds from issue of ordinary shares | $ 4,516,837 | 2,376,374 | 4,102,553 | 4,124,977 | |||||||
| Other income loss | 671,747 | 441,166 | (24,450) | (552,295) | |||||||
| Adjustments for share based payments | $ 288,883 | 198,907 | |||||||||
| Restricted share units vesting period award date description | RSUs will have a 3-year vesting period following the award date. The total number of common shares reserved and available for grant and issuance pursuant to this plan, and the total number of Restricted Share Units that may be awarded pursuant to this plan, shall not exceed 15% (in the aggregate) of the issued and outstanding common shares from time to time. | ||||||||||
| Exercise price, description | On August 7, 2024, the exercise price of the April 29, 2024 warrants were amended to CAD $0.2250 or CAD $5.625 on a post share consolidation basis. | ||||||||||
| Description of warrant | warrants were amended to CAD$3.3086 from CAD$5.625 and CAD$5.6925 respectively | ||||||||||
| Weighted average remaining contractual life of warrants | 4 years 3 months | 4 years 6 months | |||||||||
| Warrants [member] | |||||||||||
| IfrsStatementLineItems [Line Items] | |||||||||||
| Proceeds from issue of ordinary shares | $ 4,942,719 | 2,559,974 | 4,422,815 | 2,859,509 | |||||||
| Prefunded Warrants [member] | |||||||||||
| IfrsStatementLineItems [Line Items] | |||||||||||
| Proceeds from issue of ordinary shares | $ 1,977,088 | $ 591,265 | $ 1,248,343 | $ 431,084 | |||||||
| Warrant exercise price | $ / shares | $ 4.4025 | $ 0.1761 | $ 0.36 | ||||||||
| October Warrants [member] | |||||||||||
| IfrsStatementLineItems [Line Items] | |||||||||||
| New exercise price of warrants | $ / shares | $ 5.6925 | ||||||||||
| Ordinary shares [member] | |||||||||||
| IfrsStatementLineItems [Line Items] | |||||||||||
| Number of stock issued | shares | 1,200,000 | 320,000 | 258,000 | 88,000 | |||||||
| Proceeds from issue of ordinary shares | $ 329,515 | $ 160,076 | $ 396,137 | $ 2,017,966 | |||||||
| Issuance cost | $ 752,498 | ||||||||||
| Common stock 1 [member] | |||||||||||
| IfrsStatementLineItems [Line Items] | |||||||||||
| Number of shares exercise | shares | 1,991,668 | ||||||||||
| Number of stock issued | shares | 400,000 | 346,667 | 282,541 | 448,000 | |||||||
| Issued capital [member] | |||||||||||
| IfrsStatementLineItems [Line Items] | |||||||||||
| Issuance cost | $ 306 | $ 338,836 | $ 1,294,035 | ||||||||
| Shares returned to treasury shares | shares | (36,000) | (36,000) | |||||||||
| Restricted stock units [member] | |||||||||||
| IfrsStatementLineItems [Line Items] | |||||||||||
| Number of stock issued for restrcited share units | shares | 6,029 | 25,353 | |||||||||
| Share-based payment expense | $ 287,869 | $ 172,218 | |||||||||
| Stock options [member] | |||||||||||
| IfrsStatementLineItems [Line Items] | |||||||||||
| Adjustments for share based payments | $ 1,013 | $ 26,689 | |||||||||